| Dana Michelle Moulton, MD | |
|
5300 Nike Dr, Hilliard, OH 43026-9813 | |
| (614) 533-6810 | |
| (614) 777-9032 |
| Full Name | Dana Michelle Moulton |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 5300 Nike Dr, Hilliard, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396740742 | NPI | - | NPPES |
| 2580130 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35085301 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Frailty is a term which describes a loss of function as a human being over a range of physiological parameters, both physical and emotional, along with an increased susceptibility to stressful circumstances.
UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called "nanospears" for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective.
Crystal meth, a powerful addictive drug has now become such a problem in Canada that law enforcement officials met in Regina last week for a Crystal Meth Summit.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 1 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Frailty is a term which describes a loss of function as a human being over a range of physiological parameters, both physical and emotional, along with an increased susceptibility to stressful circumstances.
UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called "nanospears" for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective.
Crystal meth, a powerful addictive drug has now become such a problem in Canada that law enforcement officials met in Regina last week for a Crystal Meth Summit.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dana Michelle Moulton, MD 5400 Frantz Rd Ste 250, Dublin, OH 43016-6102 Ph: (614) 544-6155 | Dana Michelle Moulton, MD 5300 Nike Dr, Hilliard, OH 43026-9813 Ph: (614) 533-6810 |
News Archive
Frailty is a term which describes a loss of function as a human being over a range of physiological parameters, both physical and emotional, along with an increased susceptibility to stressful circumstances.
UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called "nanospears" for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective.
Crystal meth, a powerful addictive drug has now become such a problem in Canada that law enforcement officials met in Regina last week for a Crystal Meth Summit.
Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 1 days ago
Dr. Tiffany Joyce Abreu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3841 Trueman Ct, Hilliard, OH 43026 Phone: 614-777-4801 Fax: 614-777-8644 | |
Floortje Jenniskens Backes, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3651 Ridge Mill Dr, Hilliard, OH 43026 Phone: 614-293-3873 Fax: 614-293-3078 | |
Casey Cosgrove, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3651 Ridge Mill Dr, Hilliard, OH 43026 Phone: 614-293-3873 Fax: 614-293-3078 | |
Talon Jeff Anderson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5300 Nike Dr, Hilliard, OH 43026 Phone: 614-533-6810 Fax: 614-777-9032 | |
Alyson Hope Leeman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3841 Trueman Ct, Hilliard, OH 43026 Phone: 614-777-4801 Fax: 614-777-3844 | |
Jennifer L Papp, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5300 Nike Dr, Hilliard, OH 43026 Phone: 614-533-6810 Fax: 614-777-9032 | |
Jennifer A Roncone, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5300 Nike Dr, Hilliard, OH 43026 Phone: 614-533-6810 Fax: 614-777-9032 |